Clinical trials
Phase 2 Lung Diseases, Interstitial trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Terminated | 5 |
| Completed | 4 |
| Active, not recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| AllRock Bio, Inc. | 1 |
| Avalyn Pharma Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Contineum Therapeutics | 1 |
| David Palma | 1 |
| Dennis Jensen, Ph.D. | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Furiex Pharmaceuticals, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Interstitial | 18 |
| Pulmonary Fibrosis | 6 |
| Idiopathic Pulmonary Fibrosis | 5 |
| Fibrosis | 3 |
| Idiopathic Interstitial Pneumonias | 3 |
| Scleroderma, Systemic | 3 |
| Hypertension, Pulmonary | 2 |
| Lung Diseases | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Respiratory Tract Diseases | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.